Besides having a closely monitored route, the event will also have competitors again subjected to doping tests.
Organisers will be working jointly with the World Anti-Doping Agency (WADA) under its regional body, RADO and national governing body, NADO in the tests.
One of the tests that will be implemented is the Erythropoietin (EPO) test which was introduced at the 2000 Sydney Olympics.
“These are routine tests that we have always had. They are one way if ensuring the marathon measures up to IAAF standards,” stated Uganda Athletics Federation head Domenic Otuchet.
The test, validated by the International Olympic Committee (IOC), is based on the blood and urine matrix. It is the top fi ve finishers that are usually subjected to these tests.
A blood screening is performed first, and a urine test is then used to confirm possible use of EPO.
Erythropoietin (EPO) is a peptide hormone that is produced naturally by the human body.
EPO is released from the kidneys and acts on the bone marrow to stimulate red blood cell production.
An increase in red blood cells improves the amount of oxygen that the blood can carry to the body’s muscles.
By James Bakama, The New Vision